Laurion Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-160,600
| Closed | -$2.69M | – | 465 |
|
|
2024
Q2 | $2.69M | Sell |
160,600
-90,000
| -36% | -$1.51M | 0.03% | 99 |
|
|
2024
Q1 | $3.76M | Hold |
250,600
| – | – | 0.03% | 140 |
|
|
2023
Q4 | $3.76M | Sell |
250,600
-130,000
| -34% | -$1.95M | 0.03% | 86 |
|
|
2023
Q3 | $5.33M | Buy |
380,600
+11,495
| +3% | +$161K | 0.03% | 87 |
|
|
2023
Q2 | $3.82M | Sell |
369,105
-11,495
| -3% | -$119K | 0.02% | 72 |
|
|
2023
Q1 | $3.52M | Hold |
380,600
| – | – | 0.02% | 85 |
|
|
2022
Q4 | $3.38M | Hold |
380,600
| – | – | 0.02% | 94 |
|
|
2022
Q3 | $3.17M | Hold |
380,600
| – | – | 0.02% | 106 |
|
|
2022
Q2 | $3.12M | Buy |
+380,600
| New | +$3.12M | 0.05% | 88 |
|
|
2018
Q1 | – | Sell |
-47,473
| Closed | -$1.77M | – | 1337 |
|
|
2017
Q4 | $1.77M | Buy |
+47,473
| New | +$1.77M | 0.01% | 445 |
|